Euglycemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use in A Patient on The Atkins Diet: A Unique Presentation of A Known Side Effect

Euglycemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use in A Patient on The Atkins Diet: A Unique Presentation of A Known Side Effect

ABSTRACT: Objective: Euglycemic diabetic ketoacidosis (DKA) is a known potential complication from sodium-glucose cotransporter 2 (SGLT2) inhibitor use. We present a unique case presentation of a 44-year-old, male patient on an SGLT2 inhibitor who developed euglycemic DKA while following a carbohydr...

Full description

Bibliographic Details
Main Authors: Monica Sood, MD, Barbara Simon, MD, FACE, Kathleen F. Ryan, MD, Marcus Zebrower, MD
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520304636

Similar Items

Similar Items